Reverse seroconversion of hepatitis B in a haemodialysis patient

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 238-241

  Freudiger, Hans ^a   Sitavanc, Radan ^b  

^a Groupe Medical d'Onex   (Switzerland)

^b Bioanalytique Riotton   (Switzerland)

Author keywords

Case report; Haemodialysis; Hepatitis B; Lamivudine; Reverse seroconversion

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ERYTHROPOIETIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

AGED; ANEMIA; ARTICLE; CASE REPORT; DIAGNOSTIC TEST; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; LIVER FUNCTION TEST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEINURIA; SCREENING TEST; SEROCONVERSION; SYMPTOMATOLOGY;

AGED; BIOLOGICAL MARKERS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; RENAL DIALYSIS;

EID: 0346656651     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg448     Document Type: Article

References (10)

1. Marcellin P, Giostra E, Martinot-Peignoux M et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991; 100: 1432-1434
2. Blanpain C, Knoop C, Delforge M-L et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies. Transplantation 1998; 66: 883-886
3. Steinberg JL, Yeo W, Zhong S et al. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role. J Med Virol 2000; 60: 249-255
4. Vento S, Di Perri G, Luzzati R et al. Clinical reactivation of hepatitis B in anti-HBs positive patients with AIDS. Lancet 1989; 1: 332-333
5. Ambühl PM, Binswanger U, Renner EL. Epidemiology of chronic hepatitis B and C among haemodialysis patients in Switzerland. Schweiz Med Wochenschr 2000; 130: 341-348
6. Dienstag JL, Schiff ER, Wright TL et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999; 341: 1256-1263
7. Moriyama K, Nakajiami E, Hohjoh H et al. Immunoselected hepatitis B virus mutant. Lancet 1991; 337: 125
8. Kato J, Hasegawa K, Torii N et al. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology, 1996; 23: 389-395
9. Ortiz-Interian CJ, de Medina MD, Perez GO et al. Recurrence and clearance of hepatitis B surface antigenemia in a dialysis patient infected with the human deficiency virus. Am J Kidney Dis 1990; 16: 154-156
10. Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001; 120: 1009-1022